Barinthus Bio sets 0.111 share exchange ratio for Clywedog deal - BRNS News | RalliesBarinthus Bio sets 0.111 share exchange ratio for Clywedog deal
B
BRNS• Merger timing and exchange ratio set
- Barinthus Biotherapeutics’ combination with Clywedog is now expected to take effect on Sept. 3, 2026.
- Trading in Barinthus Bio ADSs on Nasdaq is expected to halt before the market opens on Sept. 3.
- The scheme exchange ratio was set at 0.111 for Topco common stock issued in exchange for scheme shares.
- Topco common stock is expected to begin trading on Nasdaq under the ticker CLYD once the deal closes.
GRML
•
